NCT00684996 Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00684853 Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD Status UNKNOWN Phase PHASE2
NCT00679029 Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer Status TERMINATED Phase PHASE2
NCT00675259 Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer Status COMPLETED Phase PHASE2
NCT00673673 FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00671372 A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00670982 Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00667394 Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors Status COMPLETED Phase PHASE2
NCT00667342 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Status COMPLETED Phase PHASE2
NCT00665990 Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia Status COMPLETED Phase PHASE1
NCT00662129 Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00661778 A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00661154 Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project Status COMPLETED Phase N/A
NCT00658697 Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer Status COMPLETED Phase PHASE2
NCT00654836 Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00653939 A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00651482 Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus) Status TERMINATED Phase PHASE2